Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy following pembrolizumab administration for advanced melanoma

被引：21
|
作者：
Sasaki, K. [1 ]
Uehara, J. [1 ]
Iinuma, S. [1 ]
Doi, H. [1 ]
Honma, M. [1 ]
Toki, Y. [2 ]
Ishida-Yamamoto, A. [1 ]
机构：
[1] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan
[2] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷 / 07期
关键词：
CYTOKINE;
D O I：
10.1093/annonc/mdy175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1602 / 1603
页数：2
相关论文
共 50 条
  • [21] Dabrafenib plus trametinib versus nivolumab for advanced melanoma
    Lahoz, Daniela
    Reyes, Felipe
    Quirland, Camila
    MEDWAVE, 2023, 23 (01):
  • [22] Acute encephalopathy with combination dabrafenib/trametinib therapy
    Cooper, Jalyn
    Kodali, Dheeraj
    Higa, Gerald M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (04) : 313 - 317
  • [23] Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma
    Zaloum, Austin
    Falet, Jean-Pierre Rene
    Elkrief, Arielle
    Chalk, Colin
    NEUROLOGY, 2020, 94 (07) : 322 - 323
  • [24] A Phase Ib/II randomised open label study of BGB324 in combination with pembrolizumab or dabrafenib/trametinib compared to pembrolizumab or dabrafenib/trametinib alone, in patients with advanced non-resectable (Stage IIIc) or metastatic (Stage IV) melanoma
    Straume, Oddbjorn
    Schuster, Cornelia
    Lorens, James
    Gjertsen, Bjorn Tore
    CANCER RESEARCH, 2017, 77
  • [25] Pembrolizumab (pembro) in combination with dabrafenib (D) and trametinib (T) for BRAF-mutant advanced melanoma: Phase 1 KEYNOTE-022 study
    Ribas, Antoni
    Hodi, F. Stephen
    Lawrence, Donald P.
    Atkinson, Victoria
    Starodub, Alexander
    Carlino, Matteo S.
    Fisher, Rosalie Anne
    Long, Georgina V.
    Miller, Wilson H.
    Huang, Yingjie
    Diede, Scott J.
    Ebbinghaus, Scot
    Hamid, Omid
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy
    Luke, Jason J.
    Ott, Patrick A.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2014, 6 : 77 - 88
  • [27] Fatal Course of a granulomatous Myocarditis under a Combination Therapy with Dabrafenib and Trametinib for metastatic Melanoma
    Buder-Bakhaya, K.
    Winkler, J.
    Herpel, E.
    Enk, A.
    Hassel, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 42 - 43
  • [28] Acneiform eruption in a patient with metastatic melanoma after ceasing combination dabrafenib/trametinib therapy
    Uribe, Pablo
    Anforth, Rachael M.
    Kefford, Richard F.
    Fernandez-Penas, Pablo
    MELANOMA RESEARCH, 2014, 24 (05) : 501 - 503
  • [29] Dabrafenib plus trametinib combination therapy triggered onset of pustulosis palmaris et plantaris in a patient with advanced cutaneous melanoma
    Muto, Yusuke
    Fujimura, Taku
    Kambayashi, Yumi
    Ohuchi, Kentaro
    Amagai, Ryo
    Okuma, Takami
    Furudate, Sadanori
    Hashimoto, Akira
    Aiba, Setsuya
    JOURNAL OF DERMATOLOGY, 2021, 48 (03): : E135 - E136
  • [30] Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma
    Cocorocchio, Emilia
    Pala, Laura
    Battaglia, Angelo
    Gandini, Sara
    Peccatori, Fedro Alessandro
    Ferrucci, Pier Francesco
    ACTA ONCOLOGICA, 2018, 57 (08) : 1131 - 1133
12345